Bacon Avocado
Bacon avocado.
I’m tired of watching women get gaslit by medical providers who haven’t kept up with the science.
Weight gain?
“Try harder.”
PCOS?
“Just lose weight.”
Perimenopause?
“Welcome to aging.”
GLP-1s aren’t just for weight loss.
They regulate insulin.
They reduce inflammation.
They support real metabolic change.
Too many providers still don’t know how GLP-1s can help women in particular — especially when it comes to hormone shifts, PCOS, and perimenopause.
If you’ve felt dismissed or discouraged — it’s not in your head.
You deserve better care.
💙 I talk about that here. Link’s in bio if you’re ready to feel heard.
#glp1
Modern healthcare often overlooks the intricate health challenges women face during hormonal shifts, such as those experienced in PCOS (Polycystic Ovary Syndrome) and perimenopause. GLP-1 (Glucagon-Like Peptide-1) receptor agonists have emerged as promising medical treatments that extend beyond weight loss to offer substantial benefits in insulin regulation, inflammation reduction, and metabolic improvement. PCOS is a complex endocrine disorder that affects millions of women worldwide, leading to insulin resistance, metabolic syndrome, and hormonal imbalances. Traditionally, management strategies focused heavily on weight loss advice, often leaving patients feeling dismissed or misunderstood. However, GLP-1 medications help regulate insulin secretion and improve glycemic control, making them a valuable therapeutic option for women struggling with PCOS-related metabolic disturbances. Similarly, perimenopause, the transition phase before menopause, involves significant hormonal fluctuations that can trigger weight gain, inflammation, and metabolic slowdown. GLP-1 therapies can support metabolic health during this phase by enhancing insulin sensitivity and reducing inflammation, which are critical for maintaining hormonal balance and overall well-being. Unfortunately, many medical providers remain unaware of these benefits, frequently attributing symptoms like weight gain or metabolic shifts solely to lifestyle or aging, which results in women experiencing inadequate care. Educating healthcare professionals and patients about the multifaceted role of GLP-1 receptor agonists is essential to advancing women’s health and combating stigma. In addition to clinical benefits, embracing GLP-1 treatments enhances quality of life by addressing underlying metabolic dysfunction rather than just symptoms. Women should feel empowered to seek care that acknowledges their unique hormonal landscapes and offers comprehensive solutions grounded in up-to-date scientific evidence. For anyone facing challenges with PCOS, perimenopause, or unexplained weight and metabolic issues, learning about GLP-1’s capabilities represents a hopeful pathway toward improved health outcomes and feeling genuinely heard by their healthcare providers.
